Harbhajan Singh thinks Indians don’t need Covid-19 vaccine, Twitter does the math for him


“Do we really need a vaccine?” Former Indian cricketer Harbhajan Singh asked on Twitter Thursday, after which the internet politely reminded the spinner exactly why the Indians (and the world) needed him.

No concrete medication in sight to COVID-19, a ray of hope appeared when some companies such as Pfizer and Moderna claimed to have developed a vaccine against COVID-19.

But vaccines are not foolproof. Since then, many have wondered how effective vaccines really were if all they offered was 90, 94, or 95 percent coverage and not a definitive solution. For some, it was a sigh of relief.

Also read: Indians have already started calling travel agents for tickets to the UK COVID-19 Vaccine

Sharing his thoughts on the vaccine situation around the world, Singh tweeted:

“PFIZER AND BIOTECH Vaccine:

Accuracy * 94%

Modern Vaccine: Accuracy * 94.5%

Oxford Vaccine: Accuracy * 90% “

Singh added that the recovery rate among Indians without a vaccine was 93.6%, suggesting that citizens of India may also eliminate the need for a vaccine entirely.

Twitterati called the tweet “careless” and threw one analogy after another with Singh explaining why a country with more than a billion inhabitants Really It needed a 100% foolproof vaccine to exist when the recovery rate was well below 100.

Read also: Pfizer and Moderna’s COVID-19 Vaccines may not be 100% foolproof, but these memes are

Meanwhile, the United Kingdom became the first country to authorize a COVID-19 vaccine on Wednesday, marking a crucial moment in the global fight against coronavirus. The Pfizer / BioNTech vaccine received an emergency clearance from British regulators and the first doses are expected to be rolled out early next week.

An independent group has been watching the trial results and the side effects of the vaccine. Pfizer and BioNTech say there were no serious side effects during the large-scale trials. To date, the Data Monitoring Committee for the study “has not reported any serious safety issues related to the vaccine,” the companies said. The only notable side effect was fatigue in some trial participants.

.